[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644592":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":40,"centralContacts":45,"locations":54,"responsibleParty":119,"collaborators":122,"id":130,"slug":131,"hasResults":132,"nctId":133,"briefTitle":134,"officialTitle":134,"acronym":135,"eligibilityCriteria":136,"healthyVolunteers":132,"sex":137,"minAge":138,"maxAge":31,"enrollmentInfo":139,"targetDuration":31,"studyType":142,"phases":143,"briefSummary":145,"conditions":146,"keywords":152,"overallStatus":158,"whyStopped":31,"lastUpdateSubmitDate":159,"lastUpdatePostDateStruct":160,"startDateStruct":163,"completionDateStruct":165,"leadSponsor":167,"locationsCount":168},{"fullName":5,"class":6},"University of Alabama at Birmingham","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A- Enhanced Usual Care","ACTIVE_COMPARATOR","Patient-reported outcomes captured; no data presented in any multidisciplinary tumor board. This group is a historical control.",[13],"Behavioral: Capture of patient-reported outcomes",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B- Enhanced Clinician Awareness","Patient-reported outcomes (PROs) captured with no personal data presented to multidisciplinary tumor board; other patient's PROs may be presented. This groups is a contemporary control.",[13,18],"Behavioral: Enhanced Clinician Awareness",{"label":20,"type":21,"description":22,"interventionNames":23},"Group C- INSPIRE intervention","EXPERIMENTAL","Patient-reported outcomes presented to multidisciplinary tumor board",[24,13,18],"Behavioral: INSPIRE (INtegrating Systematic PatIent-Reported Evaluations)",[26,32,36],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"BEHAVIORAL","INSPIRE (INtegrating Systematic PatIent-Reported Evaluations)","The INSPIRE intervention is the systematic capture and presentation of patient-reported outcomes (geriatric assessment, patient preferences, and distance to care) within multi-disciplinary tumor boards",[20],null,{"type":27,"name":33,"description":34,"armGroupLabels":35,"otherNames":31},"Capture of patient-reported outcomes","Capture of patient-reported outcomes including geriatric assessment and patient preferences",[9,15,20],{"type":27,"name":37,"description":38,"armGroupLabels":39,"otherNames":31},"Enhanced Clinician Awareness","Inclusion of patients within tumor board that may have patient-reported outcomes",[15,20],[41],{"name":42,"affiliation":43,"role":44},"Gabrielle B Rocque, MD","The University of Alabama at Birmingham","PRINCIPAL_INVESTIGATOR",[46,50],{"name":42,"role":47,"phone":48,"phoneExt":31,"email":49},"CONTACT","(205) 975-2914","grocque@uabmc.edu",{"name":51,"role":47,"phone":52,"phoneExt":31,"email":53},"Margaret A Thomas, MPH","2058421632","margaretathomas@uabmc.edu",[55,88,105],{"facility":5,"status":31,"city":56,"state":57,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Birmingham","Alabama","35294","United States","US",{"type":62,"coordinates":63},"Point",[64,65],-86.80249,33.52066,{"lat":65,"lon":64},[68,69,70,71,74,76,78,80,82,84,86],{"name":42,"role":47,"phone":48,"phoneExt":31,"email":49},{"name":51,"role":47,"phone":52,"phoneExt":31,"email":53},{"name":42,"role":44,"phone":31,"phoneExt":31,"email":31},{"name":72,"role":73,"phone":31,"phoneExt":31,"email":31},"Courtney Williams, DrPH","SUB_INVESTIGATOR",{"name":75,"role":73,"phone":31,"phoneExt":31,"email":31},"Nicole Henderson, PhD",{"name":77,"role":73,"phone":31,"phoneExt":31,"email":31},"Andres Azuero, PhD",{"name":79,"role":73,"phone":31,"phoneExt":31,"email":31},"Rebecca Arend, MD",{"name":81,"role":73,"phone":31,"phoneExt":31,"email":31},"Teresa Boitano, MD",{"name":83,"role":73,"phone":31,"phoneExt":31,"email":31},"Qasim Hussaini, MD",{"name":85,"role":73,"phone":31,"phoneExt":31,"email":31},"Bart Rose, MD",{"name":87,"role":73,"phone":31,"phoneExt":31,"email":31},"Joud El Dick, MD",{"facility":89,"status":31,"city":90,"state":91,"zip":92,"country":59,"countryCode":60,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"University of California Los Angeles (UCLA)","Los Angeles","California","90404",{"type":62,"coordinates":94},[95,96],-118.24368,34.05223,{"lat":96,"lon":95},[99,101,103],{"name":100,"role":47,"phone":31,"phoneExt":31,"email":31},"Mina Sedrak, MD, MS",{"name":102,"role":73,"phone":31,"phoneExt":31,"email":31},"Emily Martin, MD",{"name":104,"role":44,"phone":31,"phoneExt":31,"email":31},"Mina Sedrak, MD",{"facility":106,"status":31,"city":107,"state":108,"zip":109,"country":59,"countryCode":60,"cosmosGeoPoint":110,"geoPoint":114,"contacts":115},"University of Oklahoma (OU) Health Campus","Oklahoma City","Oklahoma","73126-0901",{"type":62,"coordinates":111},[112,113],-97.51643,35.46756,{"lat":113,"lon":112},[116,118],{"name":117,"role":47,"phone":31,"phoneExt":31,"email":31},"Ryan Nipp, MD",{"name":117,"role":44,"phone":31,"phoneExt":31,"email":31},{"type":44,"investigatorFullName":120,"investigatorTitle":121,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Gabrielle Rocque","Associate Professor",[123,125,127],{"name":124,"class":6},"University of Oklahoma",{"name":126,"class":6},"University of California, Los Angeles",{"name":128,"class":129},"Canopy Cancer Collective, LLC","NETWORK","100644592","integrating-systematic-patient-reported-evaluations-in-multi-disciplinary-tumor-boards-the-inspire-study-100644592",false,"NCT07671937","INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study","INSPIRE","Inclusion\u002FExclusion Criteria: We will include two populations: (1) patients and (2) clinical team members involved in the MDTB.\n\nInclusion Criteria:\n\n* Inclusions Criteria- Patients:\n\n  1. aged 18 years or older;\n  2. with suspected or confirmed diagnosis of pancreatic, breast, and gynecologic cancer (all stages) within 8 weeks of diagnosis;\n  3. intention to be treated at a participating institution;\n  4. with verbal fluency in English or Spanish; and\n  5. scheduled to be discussed at MDTB.\n* Inclusion criteria - Clinicians:\n\nAll clinical team members participating in the pancreatic, breast, or gynecologic MDTB at a participating site will be included and have pre-emptively agreed to participation.\n\nExclusion Criteria:\n\n* Exclusion criteria - Patients:\n\nIndividuals with plans to receive cancer treatment outside the participating institution and inability to speak English or Spanish.\n\n* Exclusion criteria - Clinician:\n\nClinicians will retain the opportunity to opt-out of participation, in which case their portions of the discussion will not be included in the analysis; however, this is not anticipated based on pilot data.","ALL","18 Years",{"count":140,"type":141},2748,"ESTIMATED","INTERVENTIONAL",[144],"NA","The purpose of the study is to characterize baseline multidisciplinary tumor board (MDTB) context and variability, evaluate the relationship between baseline fitness of patients with cancer and initial treatment recommendations, and assess the impact of the INSPIRE intervention, which involves including electronic patient reported outcomes (ePROs) within MDTB on MDTB discussion content, provider burden, treatment recommended and received, healthcare utilization, and patient-reported outcomes.",[147,148,149,150,151],"Breast Cancer","Corpus Uteri Cancer","Ovary Cancer","Pancreas Cancer","Other Female Genital Malignant Neoplasms",[153,154,155,156,147,157],"PROs","Multidiscipinary tumor board","INSPIRE intervention","Pancreatic Cancer","gynecologic cancers","NOT_YET_RECRUITING","2026-06-30",{"date":161,"type":162},"2026-07-02","ACTUAL",{"date":164,"type":141},"2026-09-01",{"date":166,"type":141},"2031-07",{"name":5,"class":6},3]